rs1557234938

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_000052.7(ATP7A):​c.2458G>A​(p.Ala820Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000914 in 1,094,239 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A820P) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 9.1e-7 ( 0 hom. 1 hem. )

Consequence

ATP7A
NM_000052.7 missense

Scores

9
3
2

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: 9.56

Publications

0 publications found
Variant links:
Genes affected
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]
PGK1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to phosphoglycerate kinase 1 deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.962

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP7ANM_000052.7 linkc.2458G>A p.Ala820Thr missense_variant Exon 11 of 23 ENST00000341514.11 NP_000043.4
ATP7ANM_001282224.2 linkc.2224G>A p.Ala742Thr missense_variant Exon 10 of 22 NP_001269153.1
ATP7ANR_104109.2 linkn.285-16687G>A intron_variant Intron 2 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP7AENST00000341514.11 linkc.2458G>A p.Ala820Thr missense_variant Exon 11 of 23 1 NM_000052.7 ENSP00000345728.6

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
AF:
9.14e-7
AC:
1
AN:
1094239
Hom.:
0
Cov.:
27
AF XY:
0.00000278
AC XY:
1
AN XY:
360033
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26324
American (AMR)
AF:
0.00
AC:
0
AN:
35137
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19325
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30017
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53841
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40475
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4124
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
839045
Other (OTH)
AF:
0.00
AC:
0
AN:
45951
GnomAD4 genome
Cov.:
22

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Menkes kinky-hair syndrome Uncertain:1
Mar 25, 2025
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Pathogenic
0.42
D
BayesDel_noAF
Pathogenic
0.36
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.0
.;D
LIST_S2
Pathogenic
0.99
D;D
M_CAP
Uncertain
0.26
D
MetaRNN
Pathogenic
0.96
D;D
MetaSVM
Pathogenic
0.98
D
MutationAssessor
Benign
0.0
.;M
PhyloP100
9.6
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-3.8
D;D
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Vest4
0.86
ClinPred
1.0
D
GERP RS
4.7
PromoterAI
-0.016
Neutral
Varity_R
0.76
gMVP
0.87
Mutation Taster
=16/84
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1557234938; hg19: chrX-77270210; API